Won Seog Kim

20.6k citations

462 papers · 10.8k indexed · 1 hit paper · h-index 48

Impact in

Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
Oncology top 0.2%
- Viral-associated cancers and disorders
- CAR-T cell therapy research

Papers in

Pathology and Forensic Medicine 349
- Lymphoma Diagnosis and Treatment 346
Oncology 262
- Viral-associated cancers and disorders 133
- CAR-T cell therapy research 63

Co-authors: Seok Jin Kim Young Hyeh Ko Kihyun Kım Cheolwon Suh Chul Won Jung Keunchil Park Yok‐Lam Kwong Jin Seok Kim
Journals: Blood (84 papers)Journal of Clinical Oncology (35 papers)Annals of Hematology (34 papers)Cancer Research and Treatment (23 papers)International Journal of Hematology (15 papers)
Partner nations: South Korea United States Japan

In The Last Decade

Won Seog Kim

445 papers receiving 10.7k citations

Hit Papers

align trajectories log scale

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma 2019 · 459 citations

Peers

Countries citing papers authored by Won Seog Kim

Since Specialization

Citations

This map shows the geographic impact of Won Seog Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won Seog Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won Seog Kim more than expected).

Fields of papers citing papers by Won Seog Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won Seog Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won Seog Kim. The network helps show where Won Seog Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Won Seog Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Won Seog Kim Line = papers co-authored together Won Seog Kim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study Therapeutic Advances in Hematology ·郭家樂, Jee Hyun Kong, Junshik Hong, Ja Min Byun, Sylvia Ottile Suadicani, Youngil Koh, In Ho Kim, Jinny Park, Young Rok, Jeong‐Ah Kim, Won Seog Kim, Ho‐Jin Shin, Sung Soo Yoon	2025	2
2	Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma Cancer Research and Treatment ·Sang Eun Yoon, Seung‐Ho Shin, David E. Biagas, Junhun Cho, Won Seog Kim, Seok Jin Kim	2024	6
3	QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation Transplant Infectious Disease ·Juan Y ez, Sunghwan Shin, Sooin Choi, 森田明雄, Kihyun Kım, นักวิจัย ปรัชญา ประกอบกิจ, Won Seog Kim, Chul Won Jung, Eun‐Suk Kang	2024	2
4	ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study Targeted Oncology ·Michael B. Maris, Gilles Salles, Won Seog Kim, Tae Min Kim, Roger M. Lyons, Martha Arellano, Reem Karmali, Gary J. Schiller, Elizabeth H. Cull, Camille N. Abboud, Connie Lee Batlevi, Ioannis Kagiampakis, Marlon C. Rebelatto, Young Lee, Lyndon C. Kirby, Fujun Wang, John Bothos, Danielle M. Townsley, Amir T. Fathi, Vincent Ribrag	2024	4
5	Extended follow-up results beyond 2.5 years from the pivotal NHL-1 EPCORE trial: Subcutaneous epcoritamab monotherapy in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL). Journal of Clinical Oncology ·Yasmin Karimi, Catherine Thiéblemont, Hervé Ghesquières, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Wojciech Jurczak, Kim Linton, Martin Hutchings, Tycel Phillips, Umar Farooq, Won Seog Kim, Minh H. Dinh, E I Schaieva, 克佳下地, Son Tran, Christian Winther Eskelund, Pieternella J. Lugtenburg, Julie M. Vose	2024	5
6	Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study Journal of Clinical Oncology ·Lihua E. Budde, Sarit Assouline, Laurie H. Sehn, Stephen J. Schuster, Sung‐Soo Yoon, Dok Hyun Yoon, Matthew J. Matasar, Francesc Bosch, Won Seog Kim, Loretta J. Nastoupil, Ian W. Flinn, Mazyar Shadman, Catherine Diefenbach, Chan Y. Cheah, G Hupkes, Huang Huang, Antonia Kwan, Michael C. Wei, Shen Yin, Nancy L. Bartlett	2024	34
7	A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas Clinical Cancer Research ·Won Seog Kim, Jake Shortt, Pier Luigi Zinzani, Samuel Demetouw, Dejan Radeski, Vincent Ribrag, Eva Domingo‐Doménech, Ahmed Sawas, Rawan M. Hammad, Michael Emig, Evenly B. Davidheiser, Fatima Osman A-ltom, Paulien Ravenstijn, Sheena Pinto, Pérola Mathias, Jasmine R. Cloud, Vasyl Kashchyshyn, Steven M. Horwitz	2024	7
8	Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial Clinical Lymphoma Myeloma & Leukemia ·Matthew J. Matasar, Nancy L. Bartlett, Mazyar Shadman, Lihua E. Budde, Ian W. Flinn, Gareth P. Gregory, Won Seog Kim, Georg Heß, Dima El‐Sharkawi, Catherine Diefenbach, Huang Huang, Iris To, 良市竹内, Leili Rahmatnezhad, Antonia Kwan, Sarit Assouline	2023	10
9	Comprehensive Understanding of Gut Microbiota in Treatment Naïve Diffuse Large B Cell Lymphoma Patients Blood ·Sang Eun Yoon, Woorim Kang, Mauricio Chalita, Jeong-Min Lim, Won Seog Kim, Seok Jin Kim	2021	5
10	A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies Blood ·Elizabeth Budde, Ajay K. Gopal, Won Seog Kim, Ian W. Flinn, Chan Y. Cheah, Loretta J. Nastoupil, Matthew J. Matasar, Catherine Diefenbach, Gareth P. Gregory, L. Chengyu, Hui-Yin Shaw, Maya K. Leabman, Genevive Hernandez, Asa Wheelock, Bruce A. Keyt, Daniel Chen, Philippe Armand	2021	22
11	Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34⁺ cell counts differs according to diagnosis in patients undergoing autologous peripheral blood stem cell transplantation Journal of Clinical Apheresis ·Sangmi Kim, Hyun‐Young Kim, Seok Jin Kim, Jun Ho Jang, Kihyun Kım, Won Seog Kim, Chul Won Jung, Duck Cho, Eun‐Suk Kang	2021	4
12	Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma Bone Marrow Transplantation ·Ga‐Young Song, Dok Hyun Yoon, Cheolwon Suh, Joon Ho Moon, Dong Won Baek, Jin Seok Kim, Gyeong‐Won Lee, Jun Ho Yi, Yong Park, Ki Sun Jung, Seok Jin Kim, Deok‐Hwan Yang, Won Seog Kim	2020	10
13	Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma Blood ·曾龙杨建坤, Hyehyun Jeong, Motoko Yamaguchi, Insuk Sohn, Sang Eun Yoon, Seonggyu Byeon, Joon Young Hur, Youngil Koh, Sung‐Soo Yoon, Alyssa Hansen, Masahiko Oguchi, Kana Miyazaki, Молчанова Галина Георгиевна, Dok Hyun Yoon, Junhun Cho, Young Hyeh Ko, Seok Jin Kim, Ritsuro Suzuki, Won Seog Kim	2020	17
14	Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma BMC Cancer ·Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Jung Yong Hong, Ho Sup Lee, Sung Yong Oh, Ho‐Jin Shin, Jee Hyun Kong, Jun Ho Yi, Kana Sakamoto, Young Hyeh Ko, Jooryung Huh, Seung‐Sook Lee, Kengo Takeuchi, Dong‐Yeop Shin, Cheolwon Suh, Won Seog Kim	2019	20
15	Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas American Journal of Hematology ·Francine M. Foss, Steven M. Horwitz, Monica Civallero, Monica Bellei, Luigi Marcheselli, Won Seog Kim, María Elena Cabrera, Iván Dlouhy, Arnon Nagler, Ranjana H. Advani, Emanuela Anna Pesce, Young Hyeh Ko, Silvia Montoto, Carlos Chiattone, Alison J. Moskowitz, Michele Spina, Marina Cesaretti, Irène Biasoli, Massimo Federico	2019	38
16	A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial) Leukemia & lymphoma ·P. J. Huggin, Won Seog Kim, Cheolwon Suh, Jung Yong Hong, Deok‐Hwan Yang, Won Sik Lee, Young Rok, Young‐Il Koh, Jong-Ho Won, Min Kyoung Kim, Jae‐Cheol Jo, Shin Young Hyun, Jeong‐A Kim, Young‐Ha Oh, Seung‐Sook Lee	2019	4
17	Routine Prophylaxis of Pneumocystis Pneumonia from the Fourth Cycle of R-CHOP Regimen in DLBCL Patients Blood ·Silvia Park, Seok Jin Kim, Won Seog Kim	2017	0
18	Rituximab Plus CHOP for the Treatment of Primary Mediastinal Large B Cell Lymphoma in a Pregnant Woman The Korean Journal of Internal Medicine ·Eun Kyoung Kim, Seok Jin Kim, Sung Bum Park, Jessica Bardsley, Young Hye Ko, Won Seog Kim	2011	2
19	¹⁸ F‐FDG uptake and its clinical relevance in primary gastric lymphoma Hematological Oncology ·Anna-Maria Piossek, Seok Jin Kim, Joon Young Choi, Young Hyeh Ko, Byung‐Tae Kim, Won Seog Kim	2009	33
20	The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma Blood ·Sarah Park, Jeeyun Lee, Young Hyeh Ko, Arum Han, Hyun Jung Jun, Sang Chul Lee, In Gyu Hwang, Winnie Yeo, Jin Seok Ahn, Chul Won Jung, Kihyun Kım, Yong Chan Ahn, Won Ki Kang, Keunchil Park, Won Seog Kim	2007	242

About Won Seog Kim

Won Seog Kim is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Neurology, having authored 462 papers that have together received 10.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (346 papers), Viral-associated cancers and disorders (133 papers), Chronic Lymphocytic Leukemia Research (80 papers), CNS Lymphoma Diagnosis and Treatment (66 papers), CAR-T cell therapy research (63 papers), Immune Cell Function and Interaction (53 papers), T-cell and Retrovirus Studies (29 papers) and Cutaneous lymphoproliferative disorders research (28 papers). The work is most often cited by research in Pathology and Forensic Medicine (7.1k citations), Oncology (6.3k citations), Genetics (1.8k citations), Immunology (3.0k citations) and Dermatology (873 citations). Won Seog Kim has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Seok Jin Kim, Young Hyeh Ko, Kihyun Kım, Cheolwon Suh, Chul Won Jung, Keunchil Park, Yok‐Lam Kwong, Jin Seok Kim, Jeeyun Lee and Chaehwa Park. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, Cancer Research and Treatment and International Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact